Skip to main content
. 2015 Jun 1;5(2):269–275. doi: 10.15171/apb.2015.037

Table 1. Formulation composition and its size and zeta potential values before and after radiation; data are reported as mean ± standard deviation (n = 3).

Formulation code Irradiation (kGy) e PdI Z-average (nm) Peak-1 Peak-2 Zeta potential (mV)
Size (nm) Intensity (%) Size (nm) Intensity (%)
a F1 0 0.83 ± 0.06 886 ± 28 411 ± 21 85 ± 0.3 66 ± 11 16 ± 0.9 -36 ± 2.1
1 0.63 ± 0.05 584 ± 41 424 ± 26 63 ± 0.5 4234 ± 21 35 ± 2.7 -31 ± 1.8
3 0.54 ± 0.04 529 ± 39 207 ± 28 59 ± 0.4 4300 ± 28 39 ± 3.5 -22 ± 1.2
5 0.64 ± 0.07 886 ± 26 318 ± 31 61 ± 2.6 4602 ± 32 37 ± 2.2 -32 ± 1.9
7 0.68 ± 0.05 930 ± 23 532 ± 39 55 ± 0.3 4850 ± 24 36 ± 2.1 -30 ± 2.3
b F2 0 1.12 ± 0.09 870 ± 33 429 ± 37 63 ± 0.8 45 ± 12 24 ± 0.9 -35 ± 2.7
1 0.66 ± 0.08 653 ± 41 469 ± 41 75 ± 0.2 5316 ± 24 23 ± 1.8 -33 ± 2.6
3 0.59 ± 0.06 618 ± 24 270 ± 36 59 ± 0.9 3905 ± 31 44 ± 3.4 -34 ± 2.9
5 0.81 ± 0.08 621 ± 12 378 ± 28 54 ± 0.9 4852 ± 41 39 ± 2.6 -34 ± 3.4
7 0.89 ± 0.09 661 ± 27 558 ± 31 57 ± 0.7 5461 ± 34 41 ± 3.2 -33 ± 1.4
c F3 0 0.67 ± 0.07 768 ± 19 480 ± 42 85 ± 1.1 62 ± 14 14 ± 0.9 -37 ± 3.8
1 0.55 ± 0.06 553 ± 32 263 ± 39 74 ± 0.4 5101 ± 27 22 ± 1.2 -32 ± 3.1
3 0.41 ± 0.04 492 ± 26 268 ± 29 66 ± 1.2 4041 ± 36 31 ± 2.8 -30 ± 1.9
5 0.47 ± 0.05 536 ± 31 340 ± 42 51 ± 1.6 3757 ± 38 39 ± 2.9 -35 ± 2.6
7 0.55 ± 0.06 561 ± 42 385 ± 39 56 ± 0.9 4324 ± 29 42 ± 3.4 -29 ± 2.1
d F4 0 0.71 ± 0.07 781 ± 34 519 ± 28 85 ±1.3 69 ± 10 11 ± 0.6 -36 ± 2.8
1 0.61 ± 0.06 567 ± 26 243 ± 19 75 ± 1.7 5242 ± 22 23 ± 1.1 -34 ± 3.2
3 0.55 ± 0.06 446 ± 35 178 ± 21 74 ± 0.5 5201 ± 27 21 ± 1.6 -29 ± 2.7
5 0.58 ± 0.06 487 ± 22 310 ± 33 72 ± 1.6 5001 ± 19 28 ± 1.3 -29 ± 3.1
7 0.57 ± 0.06 510 ± 31 379 ± 31 67 ± 0.8 4631 ± 23 31 ± 2.6 -30 ± 3.1

a F1: Polyacrylamide (PAAm):Polyacrylic acid (PAAc) - 1:1 (w:w), b F2: PAAm: PAAc –1:0.8 (w:w), c F3: PAAm: PAAc – 0.8:1 (w:w), d F4: PAAm: PAAc – 0.6:1 (w:w), e Polydispersity index